Arphra
live
S&P 5007,386.65+2445000.96%
NASDAQ0.00-100.00%
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1534-0.01%
GOLD4,064.2-4.50%
WTI92.99+2321.61%
BTC61,438.75-0.28%
S&P 5007,386.65+2445000.96%
NASDAQ0.00-100.00%
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1534-0.01%
GOLD4,064.2-4.50%
WTI92.99+2321.61%
BTC61,438.75-0.28%

DXR

Daxor Corporation
HealthcareMedical - Instruments & SuppliesUSUSDPeers →
$9.76
LiveJun 10, 2026
AI Brief
Market cap
$49.18M
52w range
8.45 – 14.76
P / E
EPS
Volume
3.74K
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Founded
IPO
Jul 25, 1983
Employees
37
HQ
Oak Ridge, TN
CEO
Michael Richard Feldschuh
CFO
Exchange
NASDAQ
Fiscal year
Identifiers
· company_identifiers
CIK0000027367
CUSIP239467103
ISINUS2394671034
FIGIDXR US
LEI